Tricor (fenofibrate)

The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Approval Status:

Approved February 1998

Specific Treatments:

high triglyceride levels

Therapeutic Areas

General Information

Tricor, a micronized form of the drug fenofibrate, has been approved for the treatment of very high triglyceride levels. Tricor is indicated as an adjunct to diet for the treatment of adults with very high serum triglyceride levels, specifically Types IV and V hyperlipidemia, who are not appropriately controlled by diet alone and are at risk of pancreatitis.